During a trial for a vaginal mesh lawsuit in New Jersey Superior Court in Atlantic City, a Johnson & Johnson project leader admitted vaginal mesh failure rates of at least 20 percent.
The Rottenstein Law Group is troubled by a Johnson & Johnson official’s testimony in a vaginal mesh trial that a prototype of a vaginal mesh implant failed in 20 percent of women within six months before the device even went to market in 2005, as reported in a Jan. 11 Bloomberg article.
J&J subsidiary Ethicon is currently in New Jersey Superior Court in Atlantic City defending a case (Gross v. Gynecare Inc., Atl-L-6966-10) brought by Linda Gross, 47, of South Dakota, who alleges that the company failed to adequately warn of the risks associated with the Gynecare vaginal mesh implanted to treat stress urinary incontinence and pelvic organ prolapse. Gross alleges that she received 18 surgeries to repair damage following the 2006 implantation of her Gynecare Prolift. This is the first of 1,800 vaginal mesh lawsuits set to go to trial.
Read full story at PRWeb.com: Vaginal Mesh Lawsuit Update: Rottenstein Law Group is troubled by Johnson & Johnson official’s admission of vaginal mesh failure rates of at least 20 percent